Monday, October 26, 2026 · Daily editionET --:--:--

Status not kept up to date

Minimally Invasive Robotic Surgery, Role in Optimal Debulking Ovarian Cancer, Recovery & Survival

NCT04402333 · Royal Surrey County Hospital NHS Foundation Trust · Updated 2 Sept 2020

What is being tested
Robotic Interval Debulking Surgery
For
Ovarian Cancer; Ovarian Neoplasm; Ovarian Neoplasm Epithelial; Fallopian Tube Cancer; Peritoneal Cancer
Kind of study
Watches patients without assigning a treatment. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 40 people. The full rules are on the registry page.
Where
United Kingdom
When
Starts or started 26 June 2020, ends 3 Oct 2021. Registered 26 May 2020.
Results
None posted yet.

In the researchers' words

MIRRORS "Minimally Invasive Robotic Surgery, Role in Optimal Debulking Ovarian Cancer, Recovery \& Survival" is a new United Kingdom based prospective feasibility study the purpose of which is to establish the feasibility of launching a British multicentre randomised control trial of Robotic interval debulking surgery for ovarian cancer (including cancer of the fallopian tube \& peritoneum) in the future. This initial feasibility study will focus on the ability to recruit patients, acceptability, quality of life, the rate at which it is possible to remove all visible tumour and the rate of conversion to open surgery. Ultimately the investigators would like to determine whether, in selected patients, robotic surgery offers improved quality of life and recovery with equivalent overall and progression free survival. Robotic surgery is unlikely to be suitable in all cases of ovarian cancer, particularly those with large pelvic masses or extensive disease around the upper part of the abdomen, however, it has the potential to provide significant recovery and quality of life benefits to a selected group of patients. MIRRORS - ICG "Peritoneal angiography / perfusion assessment using Indocyanine green (ICG) in patients with advanced ovarian cancers" is a ancillary study within MIRRORS. Using ICG dye, the investigators aim to observe whether there are any changes in the blood vessel…
ClinicalTrials.gov, NCT04402333

Sites

  • Royal Surrey NHS Foundation TrustGuildford, Surrey, United Kingdom